Charles Schwab’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $698M | Buy |
1,803,703
+33,208
| +2% | +$12.3M | 0.09% | 168 |
|
|
2026
Q1 | $518M | Buy |
1,770,495
+32,773
| +2% | +$10.8M | 0.08% | 214 |
|
|
2025
Q4 | $609M | Buy |
1,737,722
+51,502
| +3% | +$17.4M | 0.09% | 176 |
|
|
2025
Q3 | $545M | Sell |
1,686,220
-118,325
| -7% | -$36.8M | 0.09% | 196 |
|
|
2025
Q2 | $702M | Buy |
1,804,545
+21,892
| +1% | +$8.81M | 0.12% | 146 |
|
|
2025
Q1 | $775M | Buy |
1,782,653
+109,628
| +7% | +$44M | 0.15% | 124 |
|
|
2024
Q4 | $617M | Buy |
1,673,025
+61,783
| +4% | +$25.9M | 0.11% | 150 |
|
|
2024
Q3 | $838M | Buy |
1,611,242
+17,536
| +1% | +$9.37M | 0.16% | 110 |
|
|
2024
Q2 | $864M | Buy |
1,593,706
+28,054
| +2% | +$14.8M | 0.16% | 107 |
|
|
2024
Q1 | $812M | Buy |
1,565,652
+36,797
| +2% | +$18.3M | 0.19% | 93 |
|
|
2023
Q4 | $721M | Buy |
1,528,855
+50,701
| +3% | +$23.4M | 0.18% | 103 |
|
|
2023
Q3 | $644M | Buy |
1,478,154
+7,828
| +0.5% | +$3.55M | 0.18% | 98 |
|
|
2023
Q2 | $653M | Buy |
1,470,326
+4,072
| +0.3% | +$1.88M | 0.19% | 98 |
|
|
2023
Q1 | $674M | Buy |
1,466,254
+22,212
| +2% | +$10.6M | 0.2% | 88 |
|
|
2022
Q4 | $741M | Buy |
1,444,042
+26,167
| +2% | +$13.3M | 0.24% | 81 |
|
|
2022
Q3 | $644M | Buy |
1,417,875
+94,270
| +7% | +$45.1M | 0.23% | 84 |
|
|
2022
Q2 | $639M | Sell |
1,323,605
-9,439
| -0.7% | -$4.67M | 0.22% | 87 |
|
|
2022
Q1 | $655M | Buy |
1,333,044
+38,563
| +3% | +$17.6M | 0.2% | 96 |
|
|
2021
Q4 | $600M | Sell |
1,294,481
-6,156
| -0.5% | -$2.59M | 0.18% | 104 |
|
|
2021
Q3 | $485M | Buy |
1,300,637
+29,595
| +2% | +$11.2M | 0.16% | 117 |
|
|
2021
Q2 | $485M | Buy |
1,271,042
+21,557
| +2% | +$8.24M | 0.16% | 114 |
|
|
2021
Q1 | $449M | Sell |
1,249,485
-15,345
| -1% | -$4.93M | 0.16% | 113 |
|
|
2020
Q4 | $406M | Buy |
1,264,830
+9,232
| +0.7% | +$2.83M | 0.16% | 121 |
|
|
2020
Q3 | $337M | Sell |
1,255,598
-109,644
| -8% | -$29.5M | 0.16% | 126 |
|
|
2020
Q2 | $359M | Sell |
1,365,242
-2,670
| -0.2% | -$712K | 0.18% | 111 |
|
|
2020
Q1 | $311M | Buy |
1,367,912
+20,848
| +2% | +$5.68M | 0.18% | 105 |
|
|
2019
Q4 | $407M | Buy |
1,347,064
+21,316
| +2% | +$5.87M | 0.22% | 83 |
|
|
2019
Q3 | $318M | Buy |
1,325,748
+28,939
| +2% | +$7.93M | 0.19% | 100 |
|
|
2019
Q2 | $366M | Buy |
1,296,809
+86,892
| +7% | +$23.7M | 0.22% | 81 |
|
|
2019
Q1 | $347M | Buy |
1,209,917
+12,361
| +1% | +$3.57M | 0.22% | 81 |
|
|
2018
Q4 | $315M | Buy |
1,197,556
+9,327
| +0.8% | +$2.56M | 0.24% | 76 |
|
|
2018
Q3 | $326M | Buy |
1,188,229
+28,244
| +2% | +$7.33M | 0.22% | 79 |
|
|
2018
Q2 | $276M | Buy |
1,159,985
+12,805
| +1% | +$2.97M | 0.2% | 82 |
|
|
2018
Q1 | $252M | Buy |
1,147,180
+54,293
| +5% | +$12.8M | 0.2% | 90 |
|
|
2017
Q4 | $246M | Buy |
1,092,887
+44,632
| +4% | +$9.51M | 0.2% | 89 |
|
|
2017
Q3 | $199M | Sell |
1,048,255
-5,971
| -0.6% | -$1.14M | 0.17% | 106 |
|
|
2017
Q2 | $198M | Buy |
1,054,226
+31,870
| +3% | +$5.73M | 0.19% | 99 |
|
|
2017
Q1 | $169M | Buy |
1,022,356
+56,802
| +6% | +$9.04M | 0.17% | 111 |
|
|
2016
Q4 | $139M | Buy |
965,554
+41,819
| +5% | +$5.6M | 0.15% | 128 |
|
|
2016
Q3 | $116M | Buy |
923,735
+21,689
| +2% | +$2.8M | 0.14% | 142 |
|
|
2016
Q2 | $118M | Buy |
902,046
+30,669
| +4% | +$4.2M | 0.15% | 130 |
|
|
2016
Q1 | $121M | Buy |
871,377
+21,494
| +3% | +$2.87M | 0.16% | 122 |
|
|
2015
Q4 | $119M | Buy |
849,883
+16,371
| +2% | +$2.26M | 0.16% | 119 |
|
|
2015
Q3 | $117M | Sell |
833,512
-23,529
| -3% | -$3.54M | 0.17% | 114 |
|
|
2015
Q2 | $141M | Sell |
857,041
-4,311
| -0.5% | -$689K | 0.19% | 98 |
|
|
2015
Q1 | $133M | Buy |
861,352
+25,010
| +3% | +$3.56M | 0.19% | 107 |
|
|
2014
Q4 | $105M | Buy |
836,342
+15,622
| +2% | +$1.93M | 0.16% | 134 |
|
|
2014
Q3 | $98.2M | Sell |
820,720
-2,648
| -0.3% | -$304K | 0.16% | 127 |
|
|
2014
Q2 | $88.6M | Sell |
823,368
-1,235
| -0.1% | -$127K | 0.15% | 138 |
|
|
2014
Q1 | $82.1M | Sell |
824,603
-171,519
| -17% | -$15.5M | 0.15% | 140 |
|
|
2013
Q4 | $92M | Sell |
996,122
-141,087
| -12% | -$12.5M | 0.18% | 120 |
|
|
2013
Q3 | $97.9M | Buy |
1,137,209
+6,582
| +0.6% | +$564K | 0.2% | 107 |
|
|
2013
Q2 | $92.3M | Buy |
+1,130,627
| New | +$84.6M | 0.21% | 106 |
|
Other funds holding ELV
Charles Schwab's ELV Position: Q2 2026 in Review
Charles Schwab increased its Elevance Health (ELV) stake by 1.9% in Q2 2026, buying an estimated $12.3M and bringing the position to 1,803,703 shares worth $698M. The position accounts for 0.09% of the portfolio, ranked #168.
Charles Schwab first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $864M in Q2 2024. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Charles Schwab held 1,803,703 shares of Elevance Health worth $698M as of Q2 2026.
- Charles Schwab bought 33,208 Elevance Health shares in Q2 2026, an estimated $12.3M.
- Elevance Health made up 0.09% of Charles Schwab's portfolio in Q2 2026, its #168 holding.
- Charles Schwab first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's Elevance Health position peaked at $864M in Q2 2024.
- 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.